Jefferson Logo

News

News Releases

August 31, 2010

Explaining "How & Why" Cancer Cells Eat Us Alive: They Use Stress to Steal Nutrients from Nearby Cells to Survive, Evolve, and Spread

Four key studies now propose a new theory about how cancer cells grow and survive, allowing researchers to design better diagnostics and therapies to target high-risk cancer patients. These studies were conducted by a large team of researchers at Thomas Jefferson University's Kimmel Cancer Center.

August 31, 2010

Matthew D. Vibbert, M.D., Joins Department of Neurological Surgery at Jefferson

Matthew D. Vibbert, MD, recently joined the Thomas Jefferson University Hospital Departments of Neurology and Neurological Surgery and was named assistant professor of Neurology and Neurological Surgery at Jefferson Medical College of Thomas Jefferson University.

August 27, 2010

Jefferson Researchers Receive $3 Million NIH Grant to Study Molecular and Genetic Mechanisms in Platelets

Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.

August 19, 2010

John A. Abraham, M.D., Joins Thomas Jefferson University Hospital’s Rothman Institute

Orthopedic surgeon John A. Abraham, M.D., has joined the Rothman Institute at Jefferson. He has also been named an assistant professor of Orthopedic Surgery at Jefferson Medical College of Thomas Jefferson University and joins the faculty after serving for the past four years as a musculoskeletal oncology surgeon at the Dana-Farber Cancer Center at Harvard Medical School.

August 03, 2010

Jefferson Names Endowed Professorship in Neurological Surgery

Robert H. Rosenwasser, M.D., F.A.C.S., F.A.H.A., professor and chair, Department of Neurological Surgery at Jefferson Medical College of Thomas Jefferson University; and co-director of the Stroke Program at Thomas Jefferson University Hospital has been named to the first endowed chair in the department’s history. This endowment honors the former chair, Jewell L. Osterholm, M.D., who led the department for two decades.

Featured in the Media

Featured August 11, 2010

Jefferson Dermatologist Quoted in Businessweek About Stem Cell Treatment for Epidermolysis Bullosa

A recent study found that the rare skin blistering disease epidermolysis bullosa may be treated by bone marrow stem cell transplant. Dr. Jouni Uitto, a dermatologist at Jefferson, says that "lessening of the severe blistering to any degree is good news to the patients and their families."